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Abstract
Introduction: Most of the case of patient with hemoglobin disorder genes need routine
blood transfusion throughout their life. It leads to increase iron accumulation with liver
as the main organ for iron storage. Liver is the main organ for metabolic process,
including triglyceride and cholesterol. However, correlation between metabolism of
triglyceride and cholesterol, and iron overload condition is remain uncertain. The
purpose of this study was to investigate the effect of iron overload to triglyceride
and cholesterol level in the serum of mice.
Material & Method: Three groups of mice were divided by the dose of iron dextran (0,
0.1 and 0.3 mg/mouse). Iron dextran was injected intraperitoneally. After 14 days of
treatment, liver histology and serum triglyceride and total cholesterol were examined.
Result & Discussion: Liver weight was higher in iron dextran injected mice proportional
with dose injection. The liver histology showed normal tissue and slightly inflammation
condition with no fibrosis sign. Total cholesterol and triglyceride serum were lower
21,46% and 27,68% respectively in mice injected with 0.3 mg/mouse of iron dextran
compare to control group.
Conclusion: Iron dextran injection in 0.3 mg/mice of dose reduces cholesterol and
triglyceride serum without alteration liver morphology.
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There are about 5% ofworld population carrying hemoglobin disorder genes especially
thalassemia.[1] This condition would make individuals need routine blood transfusion
throughout their life. patient who receive regular blood transfusion will have iron accu-
mulation much higher than normal range.[2] Iron overoad condition in the body can
be defined as increase of iron deposition with no consideration about the presence of
tissue destruction.[3] Iron overload can results in organ dysfunction due to high iron
concentration which likely generates toxic free radicals and leads to parenchymal cells
destruction.[4, 5] The most affected organs caused by that condition are heart, liver,
pancreas and endocrine glands.[6–8]
In the iron overload condition, liver would have higher iron deposit leads to hepatic
iron overload condition and end up with liver fibrosis.[6, 8–10] Hepatic iron overload
would likely to generate free radicals and lipid peroxidation causing progressive hep-
atic injury result in fibrosis, cirrhosis and hepatocyte carcinoma.[11–13]
Hepatic iron overload is suggested having relation with alteration of hepatic lipid
metabolism. High iron concentration in the liver may give influence to increase activ-
ity of Acyl-CoA cholesterol Acyltransferase (ACAT) which then improve intrahepatic
cholesterol esterification and take effect in secretion of Very Low Density Lipoprotein
(VLDL) – cholesterol. Besides, hepatic iron level enhancement may cause upregulation
of the transcription of seven enzymes related to cholesterol synthesis, in other words,
it increases hepatic cholesterol synthesis.[9] Iron overload also increases intracellular
lipid droplets formation through higher expression of 1D cluster (Class 1 inconventional
MHC) which related to pathogenesis of non-alcoholic steatohepatitis.[9, 14]
The underlying mechanism of relationship between metabolism alteration due to
iron overload condition in the liver is remain uncertain. This study is aimed to inves-
tigate the effect of iron overload to triglyceride and cholesterol level in the serum of
mice.
2. Material & Method
2.1. Animals
This study was approved by Health Research Ethics Committee Faculty of Medicine
Universitas Padjadjaran The subjects of the study are 18 male mice (Mus musculus)
aged 10-12 weeks. Mice are purchased from Department of Pharmacology Faculty of
Medicine, Universitas Padjadjaran. Mice were housed in roomwith condition of 12/12 h
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light and dark cycle and adequate air circulation and had unrestricted access to water
and standard chow. Mice were adapted for 7 days before experiment.
2.2. Grouping of Experimental Groups According to
Dosage of Iron Administration
The subjects are divided in 3 groups based on the dose of iron injection:
a. Group I (control): given intraperitoneal NaCl physiologic 0.2ml injection
b. Group II: given 0.1mg/mouse intraperitoneal iron dextran injection every day
c. Group III: given 0.3mg/mouse intraperitoneal iron dextran injection every day
Every group was injected with hemadex intraperitonially with different dose for 14
days.
2.3. Measurement of Blood Glucose Concentration
On the day 3, 6, 9 and 13 we measure the blood glucose level of the mice. The mea-
surement is conducted by tail vein blood collection continued with shed the blood into
the glucometer strip (gluco DR, allmedicus, Gyeonggi-do).[15]
2.4. Organ Harvested
After 14 days, blood was collected from the infraorbital vein and kept in eppendorf
tube. Mice were sacrified by cervical dislocation technique and liver was harvested.
Liver weight was measured and stored in container tube with formaldehyde solution.
2.5. Hematoxylin & Eosin (HE) and Masson’s Trichrome Staining
of Liver Organ
For HE staining, liver organ were deparaffinize and then stained by Hematoxylin solu-
tion. After being rinsed by running tap water, it then counterstained by Eosin solution.
The liver were also stained using Masson’s Trichrome staining. Firstly, the sample
was fixated into Weigert’s iron hematoxylin. After that, it stained using three different
solutions: Biebrich scarlet, phosphomolybdic acid and methyl blue solutions.
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2.6. Measurement of Cholesterol and Triglyceride Serum
Bloodwas incubated in room temperature for 15minutes. Serumwas extracted by cen-
trifuged 1500 rpm for 30 minutes. Total cholesterol (CHOL5 RTU, Akurat Intan Madya,
Jakarta) and triglyceride (TG5RTU, Akurat Intan Madya, Jakarta) was measured based
on manufacture protocol.[15]
2.7. Statistic Analysis
Results were analyzed using one-way ANOVA for samples and Bonferroni’s posthoc
multiple comparison testswere performed to evaluate the differences between groups
A p-value <0.05 was considered as statistically significant.
3. Result and Discussion
3.1. Liver Weight/Body Weight Rasio
The measurement of liver weight showed that the liver weight of group I were 1.92 ±
0.28 gram, while group II were 2.18 ± 0.13 and group III were 2.20 ± 0.38 gram. Liver
weight of the mice was proportional with the iron injection dose.
This finding is indicated as the manifestation of liver enlargement due to increase
iron accumulation in the body, especially in the liver. When iron uptake if exceed the
capacity for export, hepatocytes will be the major site of iron reservoir. Iron accumu-
lation in the liver can be stored in non-parenchymal hepatocellular, exclusively in hep-
atocytes or mixed hepatic iron deposition in both parenchymal and non-parenchymal
hepatocellular.[13, 16]
The graphics show higher liver weight in 0.3 mg iron injection group compared to
others. However, the difference is less significant.
The ratio of liver weight/body weight showed similar trend. The ratio in group I is
55.53 ± 8.24 (mg/gr), while in group II is 53.72 ± 9.90 (mg/gr), and group III showed
48.91 ± 6.26 (mg/gr).
3.2. Liver Histology of Mice
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T 1: Liver weight of each groups (gram)
Note: 1: control group, 2: 0.1 mg iron injection group, 3: 0.3 mg iron injection group
Note: HE staining of liver in (a) control group (b) 0.1mg iron injection group and
(c) 0.3mg iron injection group. Scale bar: 100µm
Figure 1: HE staining of Mice Liver.
3.3. Total Cholesterol serum
Cholesterol serum of the group I was higher among other groups. Total cholesterol
serum of group I was 211.28± 63.04 mg/dL, while total cholesterol of group II was
186,40 ± 41,12 mg/dL and the group III was 165.94± 53.04 mg/dL. Cholesterol serum in
Mice injected with 0.3 mg/mouse of iron dextran was 20% lower compare to control,
Although the data was not statistically significant, our data showed that cholestrol
serum concentration tend to decrease after iron overload. this finding suggest that
excessive iron might diruspt genes corresponding to hepatic cholesterol synthesis.
Generally, the liver showed no inflammation state condition in all groups. The
previous study showed that there was a close connection between increase iron
intake and activation of inflammatory genes. There was increase of liver expression f
genes such as TNF-α, IL-6 IL-1β and CRP which indicate the activation of inflammatory
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Note: MT staining of liver in (a) control group (b) 0.1mg iron injection group and
(c) 0.3mg iron injection group. Scale bar: 100µm
Figure 2: Masson’s Trichrome staining of Mice Liver.
T 2: Total cholesterol serum in each groups (mg/dL).
1: control group, 2: 0.1 mg iron injection group, 3: 0.3 mg iron injection group
pathways.[19] However, we did not find fibrosis sign after the histological analysis. It
might be due to low dose and short period of iron injection
Liver is the main site of iron storage in the body and it also the important site of
lipid metabolism. Thus, iron accumulation in the liver may interact and alter hepatic
lipid metabolism.[9, 15] Previous study about alteration of cholesterol synthesis in iron
overload condition showed that from various genes related to cholesterol synthesis,
some genes showed unsignificant increase of expression while a gene showed nega-
tive correlation with increase of cholesterol synthesis.[14]
The other study also revealed decline of both forms of 3-hydroxy 3-methylglutaryl
CoA synthase (HMGCSA1, HMGCSA2)which considered as enzymes involved in de novo
synthesis of cholesterol.[17]
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3.4. Total Triglyceride serum
Total triglycerida serum of the subjects showed similar result. Total triglyceride serum
of group I was 215.11 ± 27.25 mg/dL, while group II was 240.45 ± 63.48 mg/dL and
group III was 165.94 ± 53.04 mg/dL.
T 3: Total triglyceride serum of each groups (mg/dL).
Note: 1: control group, 2: 0.1 mg iron injection group, 3: 0.3 mg iron injection group
Iron overload has corelation with lipid metabolism, however the conclusion is still
debatable. Previous study showed that iron overload might alter lipid metabolism in
liver through increase in the activity of acyl-CoA cholesterol acyltransferase (ACAT)
coupled with reduced activities of HMG CoA reductase and 7α-hydoxylase. Since ACAT
was related to VLDL-cholesterol secretion, this condition indicated upregulation of
secretory athway of lipid. Meanwhile, other study about hepatic iron overload using
carbonyl iron in the methionine-choline deficient rat model of NAFLD is associated
with decreased hepatic triglyceride.[9]
Another study of iron overload in humans homozygous for the Cys282-Tyr (C282Y)
mutation in HFE, which causes hemochromatosis, plasma low-density lipoprotein (LDL)
cholesterol has been found to be reduced. Besides, there was also negative correlation
between iron overloas and upregulation of transcriptions of Abca1 and Abcb4 which
related to cholesterol export to the plasma.[14] Therefore, reduction of triglyceride
secretion might be caused by condition mentioned above which mainly related to
decrease of VLDL secretion.
DOI 10.18502/kls.v3i6.1145 Page 375
VMIC 2017
4. Conclusion
Iron dextran injection in 0.3 mg/mice of dose reduces cholesterol and triglyceride
serum without alteration of liver morphology.
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